Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Shareholders??? Deficit (Unaudited)

v3.24.2.u1
Consolidated Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2022 $ 350,270 $ 55,141,503 $ (62,693,184) $ 150,742 $ (7,050,669)
Balance (in Shares) at Dec. 31, 2022 350,270,172        
Common stock issued for cash and accrued compensation $ 54,545 245,455 300,000
Common stock issued for cash and accrued compensation (in Shares) 54,545,455        
Common stock issued for professional fees $ 6,667 33,333 40,000
Common stock issued for professional fees (in Shares) 6,666,667        
Common stock issued for accrued compensation $ 9,636 43,364 53,000
Common stock issued for accrued compensation (in Shares) 9,636,364        
Common stock issued for conversion of Series C preferred stock $ 26,586 74,814 101,400
Common stock issued for conversion of Series C preferred stock (in Shares) 26,585,614        
Preferred stock dividends and deemed dividend (13,687) (13,687)
Accretion of stock-based compensation 12,137 12,137
Net income (loss) (706,365) (16,722) (723,087)
Balance at Mar. 31, 2023 $ 447,704 55,550,606 (63,413,236) 134,020 (7,280,906)
Balance (in Shares) at Mar. 31, 2023 447,704,272        
Balance at Dec. 31, 2022 $ 350,270 55,141,503 (62,693,184) 150,742 (7,050,669)
Balance (in Shares) at Dec. 31, 2022 350,270,172        
Net income (loss)         3,051,186
Balance at Jun. 30, 2023 $ 523,234 55,827,561 (59,633,941) 115,380 (3,167,766)
Balance (in Shares) at Jun. 30, 2023 523,233,675        
Balance at Mar. 31, 2023 $ 447,704 55,550,606 (63,413,236) 134,020 (7,280,906)
Balance (in Shares) at Mar. 31, 2023 447,704,272        
Common stock issued for professional fees $ 6,500 32,950 39,450
Common stock issued for professional fees (in Shares) 6,500,000        
Common stock issued for compensation $ 2,500 23,500   26,000
Common stock issued for compensation (in Shares) 2,500,000        
Common stock issued for conversion of Series C preferred stock $ 23,158 59,442 82,600
Common stock issued for conversion of Series C preferred stock (in Shares) 23,157,922        
Common stock issued for conversion of debt, accrued interest and fees $ 43,372 157,017 200,389
Common stock issued for conversion of debt, accrued interest and fees (in Shares) 43,371,481        
Preferred stock dividends and deemed dividend (13,618) (13,618)
Accretion of stock-based compensation 4,046 4,046
Net income (loss) 3,792,913 (18,640) 3,774,273
Balance at Jun. 30, 2023 $ 523,234 55,827,561 (59,633,941) 115,380 (3,167,766)
Balance (in Shares) at Jun. 30, 2023 523,233,675        
Balance at Dec. 31, 2023 $ 532,818 55,852,477 (60,851,714) 141,884 (4,324,535)
Balance (in Shares) at Dec. 31, 2023 532,818,051        
Common stock issued for conversion of Series C preferred stock $ 11,555 28,445 40,000
Common stock issued for conversion of Series C preferred stock (in Shares) 11,554,535        
Cancellation of Series B preferred shares $ (5,250) 132,890 127,640
Cancellation of Series B preferred shares (in Shares) (5,250,000)        
Preferred stock dividends and deemed dividend (14,349) (14,349)
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 326,968 326,968
Net income (loss) (317,158) 9,510 (307,648)
Balance at Mar. 31, 2024 $ 539,123 56,340,780 (61,183,221) 151,394 (4,151,924)
Balance (in Shares) at Mar. 31, 2024 539,122,586        
Balance at Dec. 31, 2023 $ 532,818 55,852,477 (60,851,714) 141,884 (4,324,535)
Balance (in Shares) at Dec. 31, 2023 532,818,051        
Net income (loss)         (553,617)
Balance at Jun. 30, 2024 $ 545,254 56,561,018 (61,447,146) 155,601 (4,185,273)
Balance (in Shares) at Jun. 30, 2024 545,253,623        
Balance at Mar. 31, 2024 $ 539,123 56,340,780 (61,183,221) 151,394 (4,151,924)
Balance (in Shares) at Mar. 31, 2024 539,122,586        
Common stock issued for conversion of Series C preferred stock $ 6,131 13,869 20,000
Common stock issued for conversion of Series C preferred stock (in Shares) 6,131,037        
Cancellation of Series B preferred shares 206,369 206,369
Preferred stock dividends and deemed dividend (13,749) (13,749)
Net income (loss) (250,176) 4,207 (245,969)
Balance at Jun. 30, 2024 $ 545,254 $ 56,561,018 $ (61,447,146) $ 155,601 $ (4,185,273)
Balance (in Shares) at Jun. 30, 2024 545,253,623